Bracco Diagnostics
RELATED CONTENT
Blue Earth Diagnostics, a molecular imaging diagnostics company, announced that a definitive agreement has been signed ...
June 27, 2019 
Physicians and technologists at Children’s Hospital of Philadelphia (CHOP) will be able to conduct research and education on the use of contrast ultrasound thanks to a $300,000 grant from Bracco Diagnostics Inc. USA. Contrast ultrasound is a relatively new technology that was only approved for use in pediatric patients in 2016. CHOP is among the first pediatric hospitals to use this technology in the U.S.
September 24, 2018
Bracco Diagnostics Inc. announced the labeling of its contrast agent MultiHance has obtained U.S. Food and Drug Administration (FDA) approval for an extension to include magnetic resonance imaging (MRI) of the central nervous system (CNS) in pediatric patients younger than 2 years of age (including term neonates). The agent may now be used in this patient population to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine and associated tissues.
January 30, 2018
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of ...
August 29, 2017
Here are several updates in medical imaging contrast media agents. Two of the biggest news items were related to safety ...
July 28, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to hospitals and radiology departments to control costs while meeting demand. In the CT suite, productivity and workflow can be impacted in several ways, but a new syringe-less, multi-dose multi-patient power injector is making waves at healthcare facilities with its efficiency-improving performance.
April 13, 2017
March 27, 2017 — Bracco Diagnostics Inc. announced the launch of its PROTOCO2L TOUCH Colon Insufflator. This device is ...
March 27, 2017
With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report from market research firm GlobalData.
March 02, 2017
At the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016), Bracco Diagnostics Inc. showcased a review of key milestones the company has achieved this year in diagnostic imaging and contrast media.
December 09, 2016
Bracco Diagnostics Inc. announced that CT Exprès — the first and only multi-dose, multi-patient, syringe-less injector for computed tomography (CT) according to Bracco — is now available in the United States. The CT Exprès 3-D Contrast Media Delivery System is designed to streamline workflow and optimize patient care within the CT department.
December 05, 2016
